JANX

NASD Janux Therapeutics, Inc.
Sep 30, 2026 · 6:59 AM ET LAST TRADE Market Closed

$17.07 ↑ +0.12 (+0.72%) Trading Up from the previous close of $16.95

YTD change
+23.71%
vs 20-day SMA
-3.47%
vs 200-day SMA
+14.06%

Price ranges

Previous day
$16.32 $16.98
open $16.54 close $16.95
+$0.41 (+2.48%)
Today
$0.00 $0.00
$17.07
Past week
$15.75 $17.47
from $17.47 now $17.07
-$0.40 (-2.28%)
Past month
$15.75 $20.31
from $18.22 now $17.07
-$1.15 (-6.30%)
This year
$12.12 $20.31
from $13.80 now $17.07
+$3.27 (+23.71%)

Price & Performance

+3.92 (+30.08%) / 6M

$12.45$15.24$18.03$20.82Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 76.2% away from all-time highs of $71.71
  • JANX is up 24% since the beginning of the year
  • JANX is down 30% over the past 12 months
  • JANX is down 6% over the past 1 month
  • 11% of all JANX investors are betting against JANX

JANX reads neutral: price sits above one of the two key moving averages, the 12-month move is -30.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.35
Earnings momentum +26.1% Quarterly EPS growth
Quarterly change +26.1%

Valuation

P/E ratio N/A
Enterprise value $116.9M
Beta 3.61

Balance sheet & scale

IncomeN/A
Revenue$24.0M
Cash$970.9M
Debt$21.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.0B

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.